Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study

International Journal of Cardiology

Volumn 141, Issue 2, 2010, Pages 167-174

  Ekundayo, O James ^a   Adamopoulos, Chris ^b   Ahmed, Mustafa I ^a   Pitt, Bertram ^c   Young, James B ^d   Fleg, Jerome L ^e   Love, Thomas E ^f   Sui, Xuemei ^g   Perry, Gilbert J ^a,h   Siscovick, David S ⁱ   Bakris, George ^j   Ahmed, Ali ^a,h  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF MICHIGAN   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF SOUTH CAROLINA   (United States)

^h BIRMINGHAM VA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

Heart failure; Hospitalization; Mortality; Potassium supplement; Propensity score

Indexed keywords

POTASSIUM;

ADULT; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG USE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POTASSIUM INTAKE; PRIORITY JOURNAL; SUPPLEMENTATION;

ADMINISTRATION, ORAL; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPOKALEMIA; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; POTASSIUM; PROPENSITY SCORE;

EID: 77952292213     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.195     Document Type: Article

References (31)

1. Ahmed A., Zannad F., Love T.E., et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 (2007) 1334-1343
2. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 17 (1996) 77-97
3. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
4. Rosenbaum P.R., and Rubin D.B. The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
5. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
6. Rubin D.B. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol 2 (2001) 169-188
7. Rubin D.B. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13 (2004) 855-857
8. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
9. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff Jr. D.C., and Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152 (2006) 956-966
10. Ahmed A., Aban I.B., Vaccarino V., et al. A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age. Heart 93 (2007) 1584-1590
11. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
12. Normand S.T., Landrum M.B., Guadagnoli E., et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
13. Collins J.F., Howell C.L., and Horney R.A. Determination of vital status at the end of the DIG trial. Control Clin Trials 24 (2003) 726-730
14. Rosenbaum P.R. Sensitivity to hidden bias. In: Rosenbaum P.R. (Ed). Observational Studies. 2 ed. (2002), Springer-Verlag, New York 110-124
15. SPSS for Windows. Rel. 15. program] (2008), SPSS Inc., Chicago, IL
16. Michell A.R. Relationships between individual differences in salt appetite of sheep and their plasma electrolyte status. Physiol Behav 17 (1976) 215-219
17. Michell A.R. Plasma potassium and sodium appetite; the effect of potassium infusion in sheep. Br Vet J 134 (1978) 217-224
18. Siscovick D.S., Raghunathan T.E., Psaty B.M., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330 (1994) 1852-1857
19. Laragh J.H., and Sealey J.E. K(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion. Hypertension 37 (2001) 806-810
20. Siegel D., Hulley S.B., Black D.M., et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 267 (1992) 1083-1089
21. Delgado M.C., and Delgado-Almeida A. Abnormal potassium. In: Mohler I.E.R. (Ed). Advanced Therapy in Hypertension and Vascular Disease (2006), Decker, B.C. Inc.: Elsevier 261-299
22. Packer M. Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol 65 (1990) 45E-51E
23. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
24. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
25. Weber K.T., and Villarreal D. Aldosterone and antialdosterone therapy in congestive heart failure. Am J Cardiol 71 (1993) 3A-11A
26. Gennari F.J. Hypokalemia. N Engl J Med 339 (1998) 451-458
27. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
28. Macdonald J.E., and Struthers A.D. What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol 43 (2004) 155-161
29. Petch M.C., McKay R., and Bethune D.W. The effect of beta, adrenergic blockade on serum potassium and glucose levels during open heart surgery. Eur Heart J 2 (1981) 123-126
30. Ahuja T.S., Freeman Jr. D., Mahnken J.D., Agraharkar M., Siddiqui M., and Memon A. Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am J Nephrol 20 (2000) 268-272
31. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150